9960 Stock Overview
An investment holding company, engages in the alternative and renewable energy businesses in South Africa and sub-Saharan Africa.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Renergen Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | R0.47 |
52 Week High | R1.14 |
52 Week Low | R0.45 |
Beta | 0.88 |
11 Month Change | -4.45% |
3 Month Change | -9.23% |
1 Year Change | -55.05% |
33 Year Change | -57.42% |
5 Year Change | n/a |
Change since IPO | -67.45% |
Recent News & Updates
Recent updates
Shareholder Returns
9960 | DE Oil and Gas | DE Market | |
---|---|---|---|
7D | -5.6% | 0.5% | 0.09% |
1Y | -55.0% | -37.1% | 3.1% |
Return vs Industry: 9960 underperformed the German Oil and Gas industry which returned -39.6% over the past year.
Return vs Market: 9960 underperformed the German Market which returned 3% over the past year.
Price Volatility
9960 volatility | |
---|---|
9960 Average Weekly Movement | 7.3% |
Oil and Gas Industry Average Movement | 5.0% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.7% |
10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 9960's share price has been volatile over the past 3 months.
Volatility Over Time: 9960's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | n/a | Stefano Marani | www.renergen.co.za |
Renergen Limited, an investment holding company, engages in the alternative and renewable energy businesses in South Africa and sub-Saharan Africa. The company explores for, develops, and sells compressed natural gas, as well as liquefied natural gas and helium gas. It also develops Cryo-Vacc technology, which offers transportation of vaccines at low temperature without any electrical power.
Renergen Limited Fundamentals Summary
9960 fundamental statistics | |
---|---|
Market cap | €73.24m |
Earnings (TTM) | -€5.58m |
Revenue (TTM) | €1.47m |
50.0x
P/S Ratio-13.1x
P/E RatioIs 9960 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
9960 income statement (TTM) | |
---|---|
Revenue | R28.95m |
Cost of Revenue | R35.91m |
Gross Profit | -R6.95m |
Other Expenses | R103.32m |
Earnings | -R110.27m |
Last Reported Earnings
Feb 29, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.75 |
Gross Margin | -24.02% |
Net Profit Margin | -380.88% |
Debt/Equity Ratio | 93.6% |
How did 9960 perform over the long term?
See historical performance and comparison